Cosmos Health (NASDAQ:COSM) Trading Down 2.3%

Cosmos Health Inc. (NASDAQ:COSM) shares fell 2.3% during mid-day trading on Thursday . The stock traded as low as $0.68 and last traded at $0.68. 32,702 shares traded hands during trading, a decline of 85% from the average session volume of 222,715 shares. The stock had previously closed at $0.70.

Analysts Set New Price Targets

Separately, Taglich Brothers reissued a “speculative buy” rating on shares of Cosmos Health in a research note on Tuesday, February 20th.

Cosmos Health Trading Up 2.2 %

The firm’s 50-day moving average price is $0.67 and its 200 day moving average price is $0.91. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.79 and a current ratio of 2.06.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently bought a new position in Cosmos Health stock. Armistice Capital LLC acquired a new position in shares of Cosmos Health Inc. (NASDAQ:COSM) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 1,334,937 shares of the company’s stock, valued at approximately $1,882,000. Armistice Capital LLC owned about 7.89% of Cosmos Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.